Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies

被引:0
作者
Fowzia Ibrahim
Margaret Ma
David L. Scott
Ian C. Scott
机构
[1] School of Immunology and Microbial Sciences,Centre for Rheumatic Diseases, Department of Inflammation Biology
[2] Faculty of Life Sciences and Medicine,Level 10, Tower Block, Division of Rheumatology
[3] King’s College London,Department of Medicine
[4] University Medicine Cluster,Primary Care Centre Versus Arthritis, School of Medicine
[5] National University Health System,undefined
[6] Yong Loo Lin School of Medicine,undefined
[7] National University of Singapore,undefined
[8] Keele University,undefined
[9] Haywood Academic Rheumatology Centre,undefined
[10] Haywood Hospital,undefined
[11] Midlands Partnership NHS Foundation Trust,undefined
来源
Arthritis Research & Therapy | / 24卷
关键词
Rheumatoid arthritis; Pain intensity; Disease activity assessment; Remission;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 366 条
  • [1] Strand V(2015)Patient expectations and perceptions of goal-setting strategies for disease management in rheumatoid arthritis J Rheumatol 42 2046-2054
  • [2] Wright GC(2010)Patient perceptions concerning pain management in the treatment of rheumatoid arthritis J Int Med Res 38 1213-1224
  • [3] Bergman MJ(2002)Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority Arthritis Rheum 47 391-397
  • [4] Tambiah J(2020)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Ann Rheum Dis 79 685-699
  • [5] Taylor PC(2018)EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis Ann Rheum Dis 77 797-807
  • [6] Taylor P(2020)Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib Arthritis Res Ther 22 243-2823
  • [7] Manger B(2012)Aletaha D Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity Arthritis Rheum 64 2814-1194
  • [8] Alvaro-Gracia J(2015)Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis Clin Rheumatol 34 1187-3773
  • [9] Johnstone R(2018)Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis BMC Rheumatol 2 8-92
  • [10] Gomez-Reino J(2006)Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression Arthritis Rheum 54 3761-26